Literature DB >> 30547288

Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions.

Sriram Gubbi1, Fady Hannah-Shmouni2, Constantine A Stratakis2, Christian A Koch3,4,5,6,7.   

Abstract

The pituitary gland and the hypothalamus can be affected by autoimmune-mediated structural and functional disruption. These autoimmune-mediated diseases occur more commonly in females and are often found during pregnancy or in the post-partum period. Autoimmune diseases can either affect parts of the pituitary or hypothalamus, or can involve both sellar and suprasellar structures. Most of these cases comprise primary hypophysitis (PRH). Over the years, there has been a tremendous increase in the number of reported PRH cases and related disorders, including hypophysitis induced by immune checkpoint inhibitors. With this increasing data, more light is being shed on the spectrum of clinical presentations, biochemical and imaging abnormalities of these disorders. Regardless, these disorders are still relatively rare. The clinical presentation can vary vastly, based on the type of pituitary cell or the area of the suprasellar region affected. The severity can range from clinically silent disease to progressive and rapid deterioration and death, likely due to unrecognized central adrenal insufficiency. Although biopsy remains a gold standard for diagnosing these disorders, the current standard of practice is biochemical assessment for hormonal deficiencies and imaging studies. In several instances, these disorders spontaneously resolve, but medical or surgical intervention might be necessary to treat symptomatic disease. Due to the subtlety and a vast spectrum of clinical manifestations which could often be asymptomatic, and the rarity of the occurrence of these diseases in clinical practice, the diagnosis can be easily missed which could potentially lead to substantial morbidity or mortality. Therefore, it is crucial to have a strong clinical suspicion and pursue timely biochemical and imaging studies to initiate prompt treatment. In this article, we review the various autoimmune conditions that affect the sellar and suprasellar structures, their diagnostic approach and management of these disorders.

Entities:  

Keywords:  Adrenal insufficiency; Autoimmune; Hypophysitis; IgG4; Lymphocytic; Magnetic resonance imaging; Pituitary; Suprasellar; Transsphenoidal surgery

Mesh:

Year:  2018        PMID: 30547288     DOI: 10.1007/s11154-018-9480-1

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  86 in total

1.  'Stalkitis' in a pregnant 32-year-old woman: a rare cause of diabetes insipidus.

Authors:  D A Leggett; P T Hill; R J Anderson
Journal:  Australas Radiol       Date:  1999-02

2.  Cytosolic autoantigens in lymphocytic hypophysitis.

Authors:  P A Crock
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  The spectrum and significance of primary hypophysitis.

Authors:  C C Cheung; S Ezzat; H S Smyth; S L Asa
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

4.  Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.

Authors:  Isabella Lupi; Mirco Cosottini; Patrizio Caturegli; Luca Manetti; Claudio Urbani; Daniele Cappellani; Ilaria Scattina; Enio Martino; Claudio Marcocci; Fausto Bogazzi
Journal:  Eur J Endocrinol       Date:  2017-08       Impact factor: 6.664

5.  Chronic hypernatremia associated with inflammation of the neurohypophysis.

Authors:  T Saito; S Yoshida; K Nakao; R Takanashi
Journal:  J Clin Endocrinol Metab       Date:  1970-10       Impact factor: 5.958

6.  Autoimmune orchitis induced by autoimmunization with seminal plasma in the rabbit.

Authors:  C Yantorno; M T Debanne; E Vottero-Cima
Journal:  J Reprod Fertil       Date:  1971-12

7.  Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency.

Authors:  A J Richtsmeier; R A Henry; J M Bloodworth; E N Ehrlich
Journal:  Arch Intern Med       Date:  1980-09

8.  Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings.

Authors:  E Thodou; S L Asa; G Kontogeorgos; K Kovacs; E Horvath; S Ezzat
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

9.  Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

Authors:  Romualdo Barroso-Sousa; William T Barry; Ana C Garrido-Castro; F Stephen Hodi; Le Min; Ian E Krop; Sara M Tolaney
Journal:  JAMA Oncol       Date:  2018-02-01       Impact factor: 31.777

Review 10.  Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects.

Authors:  Giuseppe Bellastella; Maria Ida Maiorino; Antonio Bizzarro; Dario Giugliano; Katherine Esposito; Antonio Bellastella; Annamaria De Bellis
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

View more
  10 in total

Review 1.  Adrenal insufficiency.

Authors:  Stefanie Hahner; Richard J Ross; Wiebke Arlt; Irina Bancos; Stephanie Burger-Stritt; David J Torpy; Eystein S Husebye; Marcus Quinkler
Journal:  Nat Rev Dis Primers       Date:  2021-03-11       Impact factor: 52.329

2.  Immunoendocrinology: When (neuro)endocrinology and immunology meet.

Authors:  Christian A Koch; Alessandro Antonelli
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

Review 3.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

4.  Isolated ACTH deficiency during single-agent pembrolizumab for squamous cell lung carcinoma: a case report.

Authors:  Sho Tanaka; Masanori Abe; Masaru Kushimoto; Tsukasa Nishizawa; Masahiro Takubo; Kazutaka Mitsuke; Jin Ikeda; Midori Fujishiro; Katsuhiko Ogawa; Ichiro Tsujino; Yutaka Suzuki
Journal:  Clin Diabetes Endocrinol       Date:  2020-01-06

5.  Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review.

Authors:  Agnese Barnabei; Silvia Carpano; Alfonsina Chiefari; Marta Bianchini; Rosa Lauretta; Marilda Mormando; Guilia Puliani; Giancarlo Paoletti; Marialuisa Appetecchia; Francesco Torino
Journal:  Front Oncol       Date:  2020-12-01       Impact factor: 6.244

6.  Full recovery from chronic headache and hypopituitarism caused by lymphocytic hypophysitis: A case report.

Authors:  Mao-Guang Yang; Han-Qing Cai; Si-Si Wang; Lin Liu; Chun-Mei Wang
Journal:  World J Clin Cases       Date:  2022-01-21       Impact factor: 1.337

7.  Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review.

Authors:  Jianyu Zhu; Zhicheng Wang; Wenze Wang; Jinghua Fan; Yi Zhang; Xiaoxu Li; Jie Liu; Shenzhong Jiang; Kan Deng; Lian Duan; Yong Yao; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-01       Impact factor: 5.555

Review 8.  Immune Checkpoint Inhibitors as a Threat to the Hypothalamus-Pituitary Axis: A Completed Puzzle.

Authors:  Agnese Barnabei; Andrea Corsello; Rosa Maria Paragliola; Giovanni Maria Iannantuono; Luca Falzone; Salvatore Maria Corsello; Francesco Torino
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

9.  Typing of inflammatory lesions of the pituitary.

Authors:  J Warmbier; D K Lüdecke; J Flitsch; M Buchfelder; R Fahlbusch; U J Knappe; J Kreutzer; R Buslei; M Bergmann; F Heppner; M Glatzel; W Saeger
Journal:  Pituitary       Date:  2021-08-31       Impact factor: 4.107

Review 10.  Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.

Authors:  Fabienne Langlois; Elena V Varlamov; Maria Fleseriu
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.